ReP USP - Resultado da busca

Artigo de periodico
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study (2014)
Witzens-Harig, Mathias; Foá, Robin; Di Rocco, Alice; Hazel, Guy van; Chamone, Dalton F. A.; Rowe, Jacob M.; Arcaini, Luca; Poddubnaya, Irina; Ho, Anthony D.; Ivanova, Valentina; Vranovsky, Andrej; Thurley, Dan; Oertel, Stephan
Source: Annals of Hematology. Unidade: FM
Subjects: LINFOMA (TERAPIA), IMUNOGLOBULINAS (ANORMALIDADES), EVENTO ADVERSO A MEDICAMENTO, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WITZENS-HARIG, Mathias et al. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study. Annals of Hematology, v. 93, n. 10, p. 1717-172451, 2014Tradução . . Disponível em: https://doi.org/10.1007/s00277-014-2153-6. Acesso em: 15 nov. 2024.
APA
Witzens-Harig, M., Foá, R., Di Rocco, A., Hazel, G. van, Chamone, D. F. A., Rowe, J. M., et al. (2014). Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study. Annals of Hematology, 93( 10), 1717-172451. doi:10.1007/s00277-014-2153-6
NLM
Witzens-Harig M, Foá R, Di Rocco A, Hazel G van, Chamone DFA, Rowe JM, Arcaini L, Poddubnaya I, Ho AD, Ivanova V, Vranovsky A, Thurley D, Oertel S. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study [Internet]. Annals of Hematology. 2014 ; 93( 10): 1717-172451.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-014-2153-6
Vancouver
Witzens-Harig M, Foá R, Di Rocco A, Hazel G van, Chamone DFA, Rowe JM, Arcaini L, Poddubnaya I, Ho AD, Ivanova V, Vranovsky A, Thurley D, Oertel S. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study [Internet]. Annals of Hematology. 2014 ; 93( 10): 1717-172451.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-014-2153-6
Trabalho de evento-resumo periodico
Association of JAK2 V617F mutation and tromboembolic events among patients with essential thrombocytemia and idiopathic myeloﬁbrosis in a Brazilian center: evidence of a retrospective study (2013)
Villaca, P. R.; Zeinad-Valim, A. K.; Okazaki, E.; Linardi, C. G.; Suganuma, L. M.; Seguro, F.; Chamone, D. A. F.; D’Amico, E. A.
Source: Journal of Thrombosis and Haemostasis. Conference titles: Congress of the International Society on Thrombosis and Haemostasis. Unidade: FM
Subjects: DOENÇAS RARAS, TROMBOEMBOLISMO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLACA, P. R. et al. Association of JAK2 V617F mutation and tromboembolic events among patients with essential thrombocytemia and idiopathic myeloﬁbrosis in a Brazilian center: evidence of a retrospective study. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf. Acesso em: 15 nov. 2024. , 2013
APA
Villaca, P. R., Zeinad-Valim, A. K., Okazaki, E., Linardi, C. G., Suganuma, L. M., Seguro, F., et al. (2013). Association of JAK2 V617F mutation and tromboembolic events among patients with essential thrombocytemia and idiopathic myeloﬁbrosis in a Brazilian center: evidence of a retrospective study. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
NLM
Villaca PR, Zeinad-Valim AK, Okazaki E, Linardi CG, Suganuma LM, Seguro F, Chamone DAF, D’Amico EA. Association of JAK2 V617F mutation and tromboembolic events among patients with essential thrombocytemia and idiopathic myeloﬁbrosis in a Brazilian center: evidence of a retrospective study [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1014-1015.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Vancouver
Villaca PR, Zeinad-Valim AK, Okazaki E, Linardi CG, Suganuma LM, Seguro F, Chamone DAF, D’Amico EA. Association of JAK2 V617F mutation and tromboembolic events among patients with essential thrombocytemia and idiopathic myeloﬁbrosis in a Brazilian center: evidence of a retrospective study [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1014-1015.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Artigo de periodico
Quantification of imatinib in human serum: Validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays (2013)
Rezende, Vinicius Marcondes; Rivellis, Ariane; Novaes, Mafalda Megumi Yoshinaga; Chamone, Dalton de Alencar Fisher; Bendit, Israel
Source: Drug Design, Development and Therapy. Unidade: FM
Subjects: LEUCEMIA MILÓIDE (TERAPIA), CROMATOGRAFIA, BIOEQUIVALÊNCIA, REAÇÃO EM CADEIA POR POLIMERASE, ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE, Vinicius Marcondes et al. Quantification of imatinib in human serum: Validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays. Drug Design, Development and Therapy, v. 7, p. 699\2013710, 2013Tradução . . Disponível em: https://doi.org/10.2147/DDDT.S42902. Acesso em: 15 nov. 2024.
APA
Rezende, V. M., Rivellis, A., Novaes, M. M. Y., Chamone, D. de A. F., & Bendit, I. (2013). Quantification of imatinib in human serum: Validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays. Drug Design, Development and Therapy, 7, 699\2013710. doi:10.2147/DDDT.S42902
NLM
Rezende VM, Rivellis A, Novaes MMY, Chamone D de AF, Bendit I. Quantification of imatinib in human serum: Validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays [Internet]. Drug Design, Development and Therapy. 2013 ; 7 699\2013710.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2147/DDDT.S42902
Vancouver
Rezende VM, Rivellis A, Novaes MMY, Chamone D de AF, Bendit I. Quantification of imatinib in human serum: Validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays [Internet]. Drug Design, Development and Therapy. 2013 ; 7 699\2013710.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2147/DDDT.S42902
Trabalho de evento-resumo periodico
Successful management of ITP during pregnancy weekly IVIg is an option: weekly IVIg is an option (2013)
Villaca, P. R.; Zeinad-Valim, A. K.; Okazaki, E.; Chamone, D. A. F.; D’Amico, E. A.
Source: Journal of Thrombosis and Haemostasis. Conference titles: Congress of the International Society on Thrombosis and Haemostasis. Unidade: FM
Subjects: FATORES DE RISCO, HEMORRAGIA, GRAVIDEZ, DOENÇAS AUTOIMUNES (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLACA, P. R. et al. Successful management of ITP during pregnancy weekly IVIg is an option: weekly IVIg is an option. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf. Acesso em: 15 nov. 2024. , 2013
APA
Villaca, P. R., Zeinad-Valim, A. K., Okazaki, E., Chamone, D. A. F., & D’Amico, E. A. (2013). Successful management of ITP during pregnancy weekly IVIg is an option: weekly IVIg is an option. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
NLM
Villaca PR, Zeinad-Valim AK, Okazaki E, Chamone DAF, D’Amico EA. Successful management of ITP during pregnancy weekly IVIg is an option: weekly IVIg is an option [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1105.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Vancouver
Villaca PR, Zeinad-Valim AK, Okazaki E, Chamone DAF, D’Amico EA. Successful management of ITP during pregnancy weekly IVIg is an option: weekly IVIg is an option [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1105.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Artigo de periodico
Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance (2013)
Ibrahim, Karim Yaqub; Pierrotti, Ligia Camera; Freire, Maristela Pinheiro; Gutierrez, Patricia Pinheiro; Duarte, Laiane do Prado Gil; Bellesso, Marcelo; Pereira, Juliana; Chamone, Dalton de Alencar Fischer; Abdala, Edson
Source: American Journal of Infection Control. Unidade: FM
Subjects: FATORES DE RISCO, INFECÇÃO HOSPITALAR, PACIENTES INTERNADOS, ESTUDOS PROSPECTIVOS, NEOPLASIAS, ASSISTÊNCIA À SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IBRAHIM, Karim Yaqub et al. Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance. American Journal of Infection Control, v. 41, n. 11, p. 1131-1133, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ajic.2013.03.299. Acesso em: 15 nov. 2024.
APA
Ibrahim, K. Y., Pierrotti, L. C., Freire, M. P., Gutierrez, P. P., Duarte, L. do P. G., Bellesso, M., et al. (2013). Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance. American Journal of Infection Control, 41( 11), 1131-1133. doi:10.1016/j.ajic.2013.03.299
NLM
Ibrahim KY, Pierrotti LC, Freire MP, Gutierrez PP, Duarte L do PG, Bellesso M, Pereira J, Chamone D de AF, Abdala E. Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance [Internet]. American Journal of Infection Control. 2013 ; 41( 11): 1131-1133.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.ajic.2013.03.299
Vancouver
Ibrahim KY, Pierrotti LC, Freire MP, Gutierrez PP, Duarte L do PG, Bellesso M, Pereira J, Chamone D de AF, Abdala E. Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance [Internet]. American Journal of Infection Control. 2013 ; 41( 11): 1131-1133.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.ajic.2013.03.299
Trabalho de evento-resumo periodico
Extracorporeal shockwave lithotripsy (ESWL) in a patient with congenital fator VII deﬁciency and von Willebrand disease (2013)
Villaca, P. R.; Zeinad-Valim, A. K.; Okazaki, E.; Rocha, R. F.; Sandoval, E. P. N.; Kato, R. B.; Chedid-Neto, E. A.; Chamone, D. A. F.; D’Amico, E. A.
Source: Journal of Thrombosis and Haemostasis. Conference titles: Congress of the International Society on Thrombosis and Haemostasis. Unidade: FM
Subjects: COAGULAÇÃO SANGUÍNEA, DOENÇA DE VON WILLEBRAND, DOENÇAS DO SISTEMA UROGENITAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLACA, P. R. et al. Extracorporeal shockwave lithotripsy (ESWL) in a patient with congenital fator VII deﬁciency and von Willebrand disease. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf. Acesso em: 15 nov. 2024. , 2013
APA
Villaca, P. R., Zeinad-Valim, A. K., Okazaki, E., Rocha, R. F., Sandoval, E. P. N., Kato, R. B., et al. (2013). Extracorporeal shockwave lithotripsy (ESWL) in a patient with congenital fator VII deﬁciency and von Willebrand disease. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
NLM
Villaca PR, Zeinad-Valim AK, Okazaki E, Rocha RF, Sandoval EPN, Kato RB, Chedid-Neto EA, Chamone DAF, D’Amico EA. Extracorporeal shockwave lithotripsy (ESWL) in a patient with congenital fator VII deﬁciency and von Willebrand disease [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1130-1131.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Vancouver
Villaca PR, Zeinad-Valim AK, Okazaki E, Rocha RF, Sandoval EPN, Kato RB, Chedid-Neto EA, Chamone DAF, D’Amico EA. Extracorporeal shockwave lithotripsy (ESWL) in a patient with congenital fator VII deﬁciency and von Willebrand disease [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1130-1131.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Artigo de periodico
Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? (2013)
Pereira, Juliana; Levy, Debora; Ruiz, Jorge L. M.; Brocardo, Graciela A.; Ferreira, Kleber A.; Costa, Renata O.; Queiroz, Rodrigo G.; Maria, Durvanei A.; Hallack Neto, Abrahao E.; Chamone, Dalton A. F.; Bydlowski, Sergio P.
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FM
Subjects: MIELOMA MÚLTIPLO (DIAGNÓSTICO), PROLIFERAÇÃO CELULAR, TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO, EXPRESSÃO GÊNICA, ZIDOVUDINA (APLICAÇÕES TERAPÊUTICAS), APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Juliana et al. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug?. Anti-Cancer Agents in Medicinal Chemistry, v. 13, n. 1, p. 186-192, 2013Tradução . . Disponível em: https://doi.org/10.2174/187152013804487416. Acesso em: 15 nov. 2024.
APA
Pereira, J., Levy, D., Ruiz, J. L. M., Brocardo, G. A., Ferreira, K. A., Costa, R. O., et al. (2013). Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? Anti-Cancer Agents in Medicinal Chemistry, 13( 1), 186-192. doi:10.2174/187152013804487416
NLM
Pereira J, Levy D, Ruiz JLM, Brocardo GA, Ferreira KA, Costa RO, Queiroz RG, Maria DA, Hallack Neto AE, Chamone DAF, Bydlowski SP. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2013 ; 13( 1): 186-192.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/187152013804487416
Vancouver
Pereira J, Levy D, Ruiz JLM, Brocardo GA, Ferreira KA, Costa RO, Queiroz RG, Maria DA, Hallack Neto AE, Chamone DAF, Bydlowski SP. Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2013 ; 13( 1): 186-192.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/187152013804487416
Trabalho de evento-resumo periodico
Acquired factor VIII inhibitor associated to prostate cancer in elderly (2013)
Villaca, P. R.; Zeinad-Valim, A. K.; Okazaki, E.; Rocha, R. F.; Chamone, D. A. F.; D’Amico, E. A.
Source: Journal of Thrombosis and Haemostasis. Conference titles: Congress of the International Society on Thrombosis and Haemostasis. Unidade: FM
Subjects: IDOSOS, HEMORRAGIA, NEOPLASIAS PROSTÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLACA, P. R. et al. Acquired factor VIII inhibitor associated to prostate cancer in elderly. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf. Acesso em: 15 nov. 2024. , 2013
APA
Villaca, P. R., Zeinad-Valim, A. K., Okazaki, E., Rocha, R. F., Chamone, D. A. F., & D’Amico, E. A. (2013). Acquired factor VIII inhibitor associated to prostate cancer in elderly. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
NLM
Villaca PR, Zeinad-Valim AK, Okazaki E, Rocha RF, Chamone DAF, D’Amico EA. Acquired factor VIII inhibitor associated to prostate cancer in elderly [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1030-1031.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Vancouver
Villaca PR, Zeinad-Valim AK, Okazaki E, Rocha RF, Chamone DAF, D’Amico EA. Acquired factor VIII inhibitor associated to prostate cancer in elderly [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 1030-1031.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf
Artigo de periodico
Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia (2012)
Nardinelli, Luciana; Sanabani, Sabri Saeed; Didone, Alline; Ferreira, Patricia de Barros; Serpa, Mariana; Novaes, Mafalda Megumi Yoshinaga; Marchiani, Mariana; Ruiz, Antonio Lancha; Lima, Ismael Severino; Chamone, Dalton de Alencar Fischer; Bendit, Israel
Source: Acta Haematologica. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, DOENÇA CRÔNICA, BIOLOGIA MOLECULAR, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDINELLI, Luciana et al. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia. Acta Haematologica, v. 127, n. 4, p. 228-234, 2012Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610. Acesso em: 15 nov. 2024.
APA
Nardinelli, L., Sanabani, S. S., Didone, A., Ferreira, P. de B., Serpa, M., Novaes, M. M. Y., et al. (2012). Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia. Acta Haematologica, 127( 4), 228-234. doi:10.1159/000336610
NLM
Nardinelli L, Sanabani SS, Didone A, Ferreira P de B, Serpa M, Novaes MMY, Marchiani M, Ruiz AL, Lima IS, Chamone D de AF, Bendit I. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia [Internet]. Acta Haematologica. 2012 ; 127( 4): 228-234.[citado 2024 nov. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610
Vancouver
Nardinelli L, Sanabani SS, Didone A, Ferreira P de B, Serpa M, Novaes MMY, Marchiani M, Ruiz AL, Lima IS, Chamone D de AF, Bendit I. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia [Internet]. Acta Haematologica. 2012 ; 127( 4): 228-234.[citado 2024 nov. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610
Artigo de periodico
Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute (2012)
Bendit, Israel; Sanabani, Sabri Saeed; Conchon, Monika; Serpa, Mariana; Novaes, Mafalda Megumi Yoshinaga; Nardinelli, Luciana; Pereira, Thales Dalessandro Meneguin; Tucunduva, Luciana; Ferreira, Patricia de Barros; Dorlhiac-Llacer, Pedro Enrique; Chamone, Dalton de Alencar Fischer
Source: Acta Haematologica. Unidade: FM
Subjects: CITOGENÉTICA MOLECULAR (AVALIAÇÃO), DOENÇA CRÔNICA, INTERFERONS, FASES, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENDIT, Israel et al. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute. Acta Haematologica, v. 128, n. 4, p. 223-232, 2012Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696. Acesso em: 15 nov. 2024.
APA
Bendit, I., Sanabani, S. S., Conchon, M., Serpa, M., Novaes, M. M. Y., Nardinelli, L., et al. (2012). Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute. Acta Haematologica, 128( 4), 223-232. doi:10.1159/000339696
NLM
Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MMY, Nardinelli L, Pereira TDM, Tucunduva L, Ferreira P de B, Dorlhiac-Llacer PE, Chamone D de AF. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute [Internet]. Acta Haematologica. 2012 ; 128( 4): 223-232.[citado 2024 nov. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696
Vancouver
Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MMY, Nardinelli L, Pereira TDM, Tucunduva L, Ferreira P de B, Dorlhiac-Llacer PE, Chamone D de AF. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute [Internet]. Acta Haematologica. 2012 ; 128( 4): 223-232.[citado 2024 nov. 15 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696
Artigo de periodico
Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies (2011)
Bellesso, Marcelo; Costa, Silvia Figueiredo; Pracchia, Luis Fernando; Chamone, Dalton Alencar Fischer; Dias, Lucia Cristina Santos; Dorlhiac-Llacer, Pedro Enrique
Source: Annals of Hematology. Unidade: FM
Subjects: ANTIBIÓTICOS (USO TERAPÊUTICO), ASSISTÊNCIA AMBULATORIAL, NEUTROFILOS (ANÁLISE), DOENÇAS HEMATOLÓGICAS (TERAPIA;QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELLESSO, Marcelo et al. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies. Annals of Hematology, v. 90, n. 4, p. 455-462, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00277-010-1073-3. Acesso em: 15 nov. 2024.
APA
Bellesso, M., Costa, S. F., Pracchia, L. F., Chamone, D. A. F., Dias, L. C. S., & Dorlhiac-Llacer, P. E. (2011). Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies. Annals of Hematology, 90( 4), 455-462. doi:10.1007/s00277-010-1073-3
NLM
Bellesso M, Costa SF, Pracchia LF, Chamone DAF, Dias LCS, Dorlhiac-Llacer PE. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies [Internet]. Annals of Hematology. 2011 ; 90( 4): 455-462.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-010-1073-3
Vancouver
Bellesso M, Costa SF, Pracchia LF, Chamone DAF, Dias LCS, Dorlhiac-Llacer PE. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies [Internet]. Annals of Hematology. 2011 ; 90( 4): 455-462.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-010-1073-3
Artigo de periodico
Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE polices in Brazil (2011)
Almeida-Neto, Cesar de; Liu, Jing; Wright, David J.; Mendrone-Junior, Alfredo; Takecian, Pedro L.; Sun, Yu; Ferreira, João Eduardo ; Chamone, Dalton de Alencar Fischer; Busch, Michael P.; Sabino, Ester Cerdeira
Source: Transfusion. Unidade: FM
Subjects: BIOMARCADORES, DOENÇAS TRANSMISSÍVEIS (PREVENÇÃO E CONTROLE), DOENÇAS INFECCIOSAS (PREVENÇÃO E CONTROLE), TRANSFUSÃO DE SANGUE, FATORES DE RISCO, CARACTERÍSTICAS DA POPULAÇÃO, CUIDADOS DE ENFERMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA-NETO, Cesar de et al. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE polices in Brazil. Transfusion, v. 51, n. 1, p. 191-197, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1537-2995.2010.02799.x. Acesso em: 15 nov. 2024.
APA
Almeida-Neto, C. de, Liu, J., Wright, D. J., Mendrone-Junior, A., Takecian, P. L., Sun, Y., et al. (2011). Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE polices in Brazil. Transfusion, 51( 1), 191-197. doi:10.1111/j.1537-2995.2010.02799.x
NLM
Almeida-Neto C de, Liu J, Wright DJ, Mendrone-Junior A, Takecian PL, Sun Y, Ferreira JE, Chamone D de AF, Busch MP, Sabino EC. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE polices in Brazil [Internet]. Transfusion. 2011 ; 51( 1): 191-197.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/j.1537-2995.2010.02799.x
Vancouver
Almeida-Neto C de, Liu J, Wright DJ, Mendrone-Junior A, Takecian PL, Sun Y, Ferreira JE, Chamone D de AF, Busch MP, Sabino EC. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE polices in Brazil [Internet]. Transfusion. 2011 ; 51( 1): 191-197.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/j.1537-2995.2010.02799.x
Trabalho de evento-resumo periodico
The relationship of MTHFR C677T polymorhisms and oral health in the incidente of oral mucositis in haematopoietic stem cell transplantation (2010)
Coracin, F. Luiz; Santos, Paulo Sérgio da Silva ; Saboya, R; Magalhães, M. Gallottini; Chamone, Dalton de Alencar Fischer; Dulley, Frederico Luiz; Nunes, Fábio Daumas
Source: Bone marrow transplantation. Conference titles: Annual meeting of the european group for blood and marrow transplantation. Unidades: FM, FO
Subjects: POLIMORFISMO, SAÚDE BUCAL, MUCOSA ORAL (FISIOPATOLOGIA), CÉLULAS-TRONCO, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORACIN, F. Luiz et al. The relationship of MTHFR C677T polymorhisms and oral health in the incidente of oral mucositis in haematopoietic stem cell transplantation. Bone marrow transplantation. Basingstoke, Hampshire: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/bmt/journal/v45/n2s/pdf/bmt201045a.pdf. Acesso em: 15 nov. 2024. , 2010
APA
Coracin, F. L., Santos, P. S. da S., Saboya, R., Magalhães, M. G., Chamone, D. de A. F., Dulley, F. L., & Nunes, F. D. (2010). The relationship of MTHFR C677T polymorhisms and oral health in the incidente of oral mucositis in haematopoietic stem cell transplantation. Bone marrow transplantation. Basingstoke, Hampshire: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/bmt/journal/v45/n2s/pdf/bmt201045a.pdf
NLM
Coracin FL, Santos PS da S, Saboya R, Magalhães MG, Chamone D de AF, Dulley FL, Nunes FD. The relationship of MTHFR C677T polymorhisms and oral health in the incidente of oral mucositis in haematopoietic stem cell transplantation [Internet]. Bone marrow transplantation. 2010 ; 45 S402.[citado 2024 nov. 15 ] Available from: http://www.nature.com/bmt/journal/v45/n2s/pdf/bmt201045a.pdf
Vancouver
Coracin FL, Santos PS da S, Saboya R, Magalhães MG, Chamone D de AF, Dulley FL, Nunes FD. The relationship of MTHFR C677T polymorhisms and oral health in the incidente of oral mucositis in haematopoietic stem cell transplantation [Internet]. Bone marrow transplantation. 2010 ; 45 S402.[citado 2024 nov. 15 ] Available from: http://www.nature.com/bmt/journal/v45/n2s/pdf/bmt201045a.pdf
Artigo de periodico
Blood Transfusion in São Paulo, Brazil: An Analysis of Blood Utilization and Recipient Survivorship at Hospital das Clinicas (2010)
Goncalez, T. T.; Capuani, L.; Liu, J.; Walsh, J.; Wright, D. J.; Ferreira, J. E.; Chamone, D. A.; Sabino, E. C.; Custer, B.
Source: Transfusion. Conference titles: Abstract presentations from the AABB annual meeting and CTTXPO. Unidade: FM
Subjects: SANGUE (ANÁLISE), ESTUDOS RETROSPECTIVOS, TRANSFUSÃO DE SANGUE, RESUMOS (EVENTOS), SÃO PAULO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONCALEZ, T. T. et al. Blood Transfusion in São Paulo, Brazil: An Analysis of Blood Utilization and Recipient Survivorship at Hospital das Clinicas. Transfusion, v. 50, n. 2S, p. 186A, 2010Tradução . . Acesso em: 15 nov. 2024.
APA
Goncalez, T. T., Capuani, L., Liu, J., Walsh, J., Wright, D. J., Ferreira, J. E., et al. (2010). Blood Transfusion in São Paulo, Brazil: An Analysis of Blood Utilization and Recipient Survivorship at Hospital das Clinicas. Transfusion, 50( 2S), 186A.
NLM
Goncalez TT, Capuani L, Liu J, Walsh J, Wright DJ, Ferreira JE, Chamone DA, Sabino EC, Custer B. Blood Transfusion in São Paulo, Brazil: An Analysis of Blood Utilization and Recipient Survivorship at Hospital das Clinicas. Transfusion. 2010 ; 50( 2S): 186A.[citado 2024 nov. 15 ]
Vancouver
Goncalez TT, Capuani L, Liu J, Walsh J, Wright DJ, Ferreira JE, Chamone DA, Sabino EC, Custer B. Blood Transfusion in São Paulo, Brazil: An Analysis of Blood Utilization and Recipient Survivorship at Hospital das Clinicas. Transfusion. 2010 ; 50( 2S): 186A.[citado 2024 nov. 15 ]
Artigo de periodico
Association Between FYB-33/FYB-33 Genotype and Lower Red Blood Cell Transfusion Rate in Sickle Cell Disease Patients (2010)
Novaretti, M. C.; Abreu, S. F.; Medeiros, V. R.; Dorlhiac-Llacer, P. E.; Chamone, D. A.
Source: Transfusion. Conference titles: Abstract presentations from the AABB annual meeting and CTTXPO. Unidade: FM
Subjects: GENÓTIPOS, DOENÇAS HEMATOLÓGICAS, ANEMIA FALCIFORME, TRANSFUSÃO DE SANGUE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVARETTI, M. C. et al. Association Between FYB-33/FYB-33 Genotype and Lower Red Blood Cell Transfusion Rate in Sickle Cell Disease Patients. Transfusion, v. 50, n. 2S, p. 140A, 2010Tradução . . Acesso em: 15 nov. 2024.
APA
Novaretti, M. C., Abreu, S. F., Medeiros, V. R., Dorlhiac-Llacer, P. E., & Chamone, D. A. (2010). Association Between FYB-33/FYB-33 Genotype and Lower Red Blood Cell Transfusion Rate in Sickle Cell Disease Patients. Transfusion, 50( 2S), 140A.
NLM
Novaretti MC, Abreu SF, Medeiros VR, Dorlhiac-Llacer PE, Chamone DA. Association Between FYB-33/FYB-33 Genotype and Lower Red Blood Cell Transfusion Rate in Sickle Cell Disease Patients. Transfusion. 2010 ; 50( 2S): 140A.[citado 2024 nov. 15 ]
Vancouver
Novaretti MC, Abreu SF, Medeiros VR, Dorlhiac-Llacer PE, Chamone DA. Association Between FYB-33/FYB-33 Genotype and Lower Red Blood Cell Transfusion Rate in Sickle Cell Disease Patients. Transfusion. 2010 ; 50( 2S): 140A.[citado 2024 nov. 15 ]
Artigo de periodico
Genotype Duffy and Alloimmunization Against Blood Group Antigens Risk in Patients with Sickle Cell Disease (2010)
Novaretti, M. C.; Abreu, S. F.; Medeiros, V. R.; Dorlhiac-Llacer, P. E.; Chamone, D. A.
Source: Transfusion. Conference titles: Abstract presentations from the AABB annual meeting and CTTXPO. Unidade: FM
Subjects: GENÓTIPOS, IMUNIZAÇÃO, ANEMIA FALCIFORME, GRUPOS SANGUÍNEOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVARETTI, M. C. et al. Genotype Duffy and Alloimmunization Against Blood Group Antigens Risk in Patients with Sickle Cell Disease. Transfusion, v. 50, n. 2S, p. 139A, 2010Tradução . . Acesso em: 15 nov. 2024.
APA
Novaretti, M. C., Abreu, S. F., Medeiros, V. R., Dorlhiac-Llacer, P. E., & Chamone, D. A. (2010). Genotype Duffy and Alloimmunization Against Blood Group Antigens Risk in Patients with Sickle Cell Disease. Transfusion, 50( 2S), 139A.
NLM
Novaretti MC, Abreu SF, Medeiros VR, Dorlhiac-Llacer PE, Chamone DA. Genotype Duffy and Alloimmunization Against Blood Group Antigens Risk in Patients with Sickle Cell Disease. Transfusion. 2010 ; 50( 2S): 139A.[citado 2024 nov. 15 ]
Vancouver
Novaretti MC, Abreu SF, Medeiros VR, Dorlhiac-Llacer PE, Chamone DA. Genotype Duffy and Alloimmunization Against Blood Group Antigens Risk in Patients with Sickle Cell Disease. Transfusion. 2010 ; 50( 2S): 139A.[citado 2024 nov. 15 ]
Artigo de periodico
Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil (2010)
Lopes, Renato D.; Garcia, David; Becker, Richard C.; Granger, Christopher B.; Newby, L. Kristin; Alexander, John H.; Jolicoeur, E. Marc; Handler, Allison; Pieper, Karen S.; Carvalho, Antonio C.; Guimaraes, Helio P.; Chamone, Dalton A. F.; Baruzzi, Antonio C.; Machado, Fabio S.; Timerman, Ari; Lopes, Antonio C.
Source: Journal of Thrombosis and Thrombolysis. Unidade: FM
Subjects: TROMBOSE (COMPLICAÇÕES;TERAPIA), SISTEMA CARDIOVASCULAR, BIOMARCADORES, TOMADA DE DECISÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Renato D. et al. Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil. Journal of Thrombosis and Thrombolysis, v. 29, n. 4, p. 395-408, 2010Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs11239-010-0454-8.pdf. Acesso em: 15 nov. 2024.
APA
Lopes, R. D., Garcia, D., Becker, R. C., Granger, C. B., Newby, L. K., Alexander, J. H., et al. (2010). Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil. Journal of Thrombosis and Thrombolysis, 29( 4), 395-408. doi:10.1007/s11239-010-0454-8
NLM
Lopes RD, Garcia D, Becker RC, Granger CB, Newby LK, Alexander JH, Jolicoeur EM, Handler A, Pieper KS, Carvalho AC, Guimaraes HP, Chamone DAF, Baruzzi AC, Machado FS, Timerman A, Lopes AC. Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil [Internet]. Journal of Thrombosis and Thrombolysis. 2010 ; 29( 4): 395-408.[citado 2024 nov. 15 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs11239-010-0454-8.pdf
Vancouver
Lopes RD, Garcia D, Becker RC, Granger CB, Newby LK, Alexander JH, Jolicoeur EM, Handler A, Pieper KS, Carvalho AC, Guimaraes HP, Chamone DAF, Baruzzi AC, Machado FS, Timerman A, Lopes AC. Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil [Internet]. Journal of Thrombosis and Thrombolysis. 2010 ; 29( 4): 395-408.[citado 2024 nov. 15 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs11239-010-0454-8.pdf
Artigo de periodico
A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil (2010)
Tanaka, Paula Yurie; Pracchia, Luis Fernando; Bellesso, Marcelo; Chamone, Dalton Alencar Fischer; Calore, Edenilson Eduardo; Pereira, Juliana
Source: Annals of Hematology. Unidade: FM
Subjects: PROGNÓSTICO, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, LINFOMA (PATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANAKA, Paula Yurie et al. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil. Annals of Hematology, v. 89, n. 1, p. 45-51, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00277-009-0761-3. Acesso em: 15 nov. 2024.
APA
Tanaka, P. Y., Pracchia, L. F., Bellesso, M., Chamone, D. A. F., Calore, E. E., & Pereira, J. (2010). A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil. Annals of Hematology, 89( 1), 45-51. doi:10.1007/s00277-009-0761-3
NLM
Tanaka PY, Pracchia LF, Bellesso M, Chamone DAF, Calore EE, Pereira J. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil [Internet]. Annals of Hematology. 2010 ; 89( 1): 45-51.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-009-0761-3
Vancouver
Tanaka PY, Pracchia LF, Bellesso M, Chamone DAF, Calore EE, Pereira J. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil [Internet]. Annals of Hematology. 2010 ; 89( 1): 45-51.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00277-009-0761-3
Trabalho de evento-resumo periodico
Survival rate among recipients of blood in a main public hospital in São Paulo, Brazil (2010)
Capuani, L.; Custer, B.; Goncalez, T. T.; Jing, E. L.; Silva, P. P.; Ferreira, J. E.; Chamone, D. F.; Murphy, E.; Busch, M. P.; Sabino, E. C.
Source: Vox Sanguinis- International Journal Of Transfusion Medicine. Conference titles: International Congress of the International Society of Blood Transfusion in joint cooperation with the. Unidade: FM
Subjects: TRANSFUSÃO DE SANGUE (COMPLICAÇÕES;MORTALIDADE), HOSPITAIS PÚBLICOS, SÃO PAULO (SP)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAPUANI, L. et al. Survival rate among recipients of blood in a main public hospital in São Paulo, Brazil. Vox Sanguinis- International Journal Of Transfusion Medicine. Basel: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf. Acesso em: 15 nov. 2024. , 2010
APA
Capuani, L., Custer, B., Goncalez, T. T., Jing, E. L., Silva, P. P., Ferreira, J. E., et al. (2010). Survival rate among recipients of blood in a main public hospital in São Paulo, Brazil. Vox Sanguinis- International Journal Of Transfusion Medicine. Basel: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf
NLM
Capuani L, Custer B, Goncalez TT, Jing EL, Silva PP, Ferreira JE, Chamone DF, Murphy E, Busch MP, Sabino EC. Survival rate among recipients of blood in a main public hospital in São Paulo, Brazil [Internet]. Vox Sanguinis- International Journal Of Transfusion Medicine. 2010 ; 99 108.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf
Vancouver
Capuani L, Custer B, Goncalez TT, Jing EL, Silva PP, Ferreira JE, Chamone DF, Murphy E, Busch MP, Sabino EC. Survival rate among recipients of blood in a main public hospital in São Paulo, Brazil [Internet]. Vox Sanguinis- International Journal Of Transfusion Medicine. 2010 ; 99 108.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf
Trabalho de evento-resumo periodico
Evaluation of PCR-SSP and real time PCR using fluorescent dye and melting curve analysis for KEL*1/KEL*2 genotyping (2010)
Novaretti, C. Z.; Ruiz, A. S.; Medeiros, V. R.; Abreu, S. M. F.; Bonifácio, S. L.; Dorlhiac-Llacer, P. E.; Chamone, D. A. F.
Source: Vox Sanguinis- International Journal Of Transfusion Medicine. Conference titles: International Congress of the International Society of Blood Transfusion in joint cooperation with the. Unidade: FM
Subjects: REAÇÃO EM CADEIA POR POLIMERASE (AVALIAÇÃO), GRUPOS SANGUÍNEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVARETTI, C. Z. et al. Evaluation of PCR-SSP and real time PCR using fluorescent dye and melting curve analysis for KEL*1/KEL*2 genotyping. Vox Sanguinis- International Journal Of Transfusion Medicine. Basel: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf. Acesso em: 15 nov. 2024. , 2010
APA
Novaretti, C. Z., Ruiz, A. S., Medeiros, V. R., Abreu, S. M. F., Bonifácio, S. L., Dorlhiac-Llacer, P. E., & Chamone, D. A. F. (2010). Evaluation of PCR-SSP and real time PCR using fluorescent dye and melting curve analysis for KEL*1/KEL*2 genotyping. Vox Sanguinis- International Journal Of Transfusion Medicine. Basel: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf
NLM
Novaretti CZ, Ruiz AS, Medeiros VR, Abreu SMF, Bonifácio SL, Dorlhiac-Llacer PE, Chamone DAF. Evaluation of PCR-SSP and real time PCR using fluorescent dye and melting curve analysis for KEL*1/KEL*2 genotyping [Internet]. Vox Sanguinis- International Journal Of Transfusion Medicine. 2010 ; 99 271.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf
Vancouver
Novaretti CZ, Ruiz AS, Medeiros VR, Abreu SMF, Bonifácio SL, Dorlhiac-Llacer PE, Chamone DAF. Evaluation of PCR-SSP and real time PCR using fluorescent dye and melting curve analysis for KEL*1/KEL*2 genotyping [Internet]. Vox Sanguinis- International Journal Of Transfusion Medicine. 2010 ; 99 271.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2010.01343_2.x/pdf

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Indexado em

Normalized affiliation

Non normalized affiliation